Evidence map›Paper›PMID 38766548›Full record

ArticleINNOSC theranostics & pharmacological sciences2024

Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.

Kenneth Blum, Eric R Braverman, Mark S Gold, Catherine A Dennen, David Baron, Panayotis K Thanos, Colin Hanna, Igor Elman, Marjorie C Gondre-Lewis, J Wesson Ashford and 11 more

Abstract read
In one paragraph

Article in INNOSC theranostics & pharmacological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kenneth BlumDivision of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, California, United States of America.
Eric R BravermanThe Kenneth Blum Behavioral and Neurogenetic Institute LLC, Austin, Texas, United States of America.
Mark S GoldDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Catherine A DennenDepartment of Family Medicine, Jefferson Health Northeast, Philadelphia, Pennsylvania, United States of America.
David BaronDivision of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, California, United States of America.
Panayotis K ThanosDepartment of Psychology and Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University of Buffalo, Buffalo, New York, United States of America.
Colin HannaDepartment of Psychology and Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University of Buffalo, Buffalo, New York, United States of America.
Igor ElmanCambridge Health Alliance, Harvard Medical School, Cambridge, Massachusetts, United States of America.
Marjorie C Gondre-LewisDepartment of Anatomy, Howard University School of Medicine, Washington, D.C., United States of America.
J Wesson AshfordDepartment of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California, United States of America.
Andrew NewbergDepartment of Integrative Medicine and Nutritional Sciences, Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania, United States of America.
Margaret A MadiganThe Kenneth Blum Behavioral and Neurogenetic Institute LLC, Austin, Texas, United States of America.
Nicole JafariDivision of Personalized Medicine, Cross-Cultural Research and Educational Institute, San Clemente, California, United States of America.
Foojan ZeineDepartment of Human Development, California State University at Long Beach, Long Beach, California, United States of America.
Keerthy SunderDepartment of Health Science, California State University at Long Beach, Long Beach, California, United States of America.
John GiordanoDivision of Personalized Medicine, Ketamine Clinic of South Florida, Pompano Beach, Florida, United States of America.
Debmayla BarhCentre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology, Purba Medinipur, West Bengal, India.
Ashim GuptaFuture Biologics, Lawrenceville, Georgia, United States of America.
Paul CarneyDivision of Pediatric Neurology, University of Missouri Health Care-Columbia, Columbia, Missouri, United States of America.
Abdalla BowirratDepartment of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel, Israel.
Rajendra D BadgaiyanDepartment of Psychiatry, Mt. Sinai School of Medicine, New York City, New York, United States of America.

Funding

Dopamine Neurotransmission in AddictionI01CX000479 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI BADGAIYAN, RAJENDRA D · 2013 to 2014
–
CSRD VA I01 CX000479
6 · The paper itself

Abstract

The Carter Center has estimated that the addiction crisis in the United States (US), if continues to worsen at the same rate, may cost the country approximately 16 trillion dollars by 2030. In recent years, the well-being of youth has been compromised by not only the coronavirus disease 2019 pandemic but also the alarming global opioid crisis, particularly in the US. Each year, deadly opioid drugs claim hundreds of thousands of lives, contributing to an ever-rising death toll. In addition, maternal usage of opioids and other drugs during pregnancy could compromise the neurodevelopment of children. A high rate of DNA polymorphic antecedents compounds the occurrence of epigenetic insults involving methylation of specific essential genes related to normal brain function. These genetic antecedent insults affect healthy DNA and mRNA transcription, leading to a loss of proteins required for normal brain development and function in youth. Myelination in the frontal cortex, a process known to extend until the late 20s, delays the development of proficient executive function and decision-making abilities. Understanding this delay in brain development, along with the presence of potential high-risk antecedent polymorphic variants or alleles and generational epigenetics, provides a clear rationale for embracing the Brain Research Commission's suggestion to mimic fitness programs with an adaptable brain health check (BHC). Implementing the BHC within the educational systems in the US and other countries could serve as an effective initiative for proactive therapies aimed at reducing juvenile mental health problems and eventually criminal activities, addiction, and other behaviors associated with reward deficiency syndrome.

Indexed as

Brain health checkCognitionDopaminergic dysregulationEpigeneticsExecutive functionGeneticsReward deficiency syndrome

Identifiers

PMID38766548
PMCPMC11100020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.